{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:32:12Z","timestamp":1790872332437,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>AIDS-associated cryptococcal meningitis has a high mortality. Fluconazole was the only systemic antifungal therapy available in our centre. From 1999\u20132001 we used low-dose fluconazole (200 mg daily initially), and did not offer therapy to patients perceived to have poor prognoses. In 2001 donated fluconazole became available, allowing us to use standard doses (400 mg daily initially). Antiretroviral therapy was not available during the study period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective chart review of adult patients before and after the fluconazole donation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>205 patients fulfilled the inclusion criteria, 77 before and 128 after the donation. Following the donation fewer patients received no antifungal treatment (5% vs 19%, p = 0.002), and more patients received standard-dose fluconazole (90% vs 6%, p &lt; 0.001). In-hospital mortality was 25%. Impaired consciousness, no antifungal treatment received and cerebrospinal fluid antigen titre &gt; 1,000 were independent predictors of in-hospital mortality. Concomitant rifampicin did not affect in-hospital survival. Thirteen patients were referred to the tertiary referral hospital and received initial treatment with amphotericin B for a mean of 6 days \u2013 their in-hospital survival was not different from patients who received only fluconazole (p = 0.9). Kaplan-Meier analysis showed no differences in length of survival by initial treatment with standard or low doses of fluconazole (p = 0.27 log rank test); median survival was 76 and 82 days respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Outcome of AIDS-associated cryptococcal meningitis is similar with low or standard doses of fluconazole. The early mortality is high. Initial therapy with amphotericin B and other measures may be needed to improve outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-6-118","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T19:30:00Z","timestamp":1153251000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg\/day or 400 mg\/day of fluconazole"],"prefix":"10.1186","volume":"6","author":[{"given":"CF","family":"Schaars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GA","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Morroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/bmb\/ldh043","volume":"72","author":"T Bicanic","year":"2005","unstructured":"Bicanic T, Harrison TS: Cryptococcal meningitis. Br Med Bull. 2005, 72: 99-118. 10.1093\/bmb\/ldh043.","journal-title":"Br Med Bull"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1086\/368091","volume":"36","author":"SA Mirza","year":"2003","unstructured":"Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, Ponce de Leon G, Baughman W, Hajjeh RA: The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000. Clin Infect Dis. 2003, 36: 789-794. 10.1086\/368091.","journal-title":"Clin Infect Dis"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1086\/515074","volume":"28","author":"PA Robinson","year":"1999","unstructured":"Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DM, Leedom JM, Larsen RA: Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999, 28: 82-92.","journal-title":"Clin Infect Dis"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly W, Sobel JD, Dismukes WE: Practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2000, 30: 710-8. 10.1086\/313757.","journal-title":"Clin Infect Dis"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJM199707033370103","volume":"337","author":"CM Van der Horst","year":"1997","unstructured":"Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 1997, 337: 15-21. 10.1056\/NEJM199707033370103.","journal-title":"N Engl J Med"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1473-3099(05)70197-3","volume":"5","author":"T Bicanic","year":"2005","unstructured":"Bicanic T, Wood R, Bekker LG, Darder M, Meintjes G, Harrison TS: Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis. Lancet Infect Dis. 2005, 5: 530-1. 10.1016\/S1473-3099(05)70197-3.","journal-title":"Lancet Infect Dis"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/pmj.77.914.769","volume":"77","author":"P Mwaba","year":"2001","unstructured":"Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, Zumla A: Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001, 77: 769-73. 10.1136\/pmj.77.914.769.","journal-title":"Postgrad Med J"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinids\/24.2.131","volume":"24","author":"MY Moosa","year":"1997","unstructured":"Moosa MY, Coovadia YM: Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV) \u2013 positive and HIV-negative patients. Clin Infect Dis. 1997, 24: 131-4.","journal-title":"Clin Infect Dis"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJM199201093260202","volume":"326","author":"MS Saag","year":"1992","unstructured":"Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med. 1992, 326: 83-9.","journal-title":"N Engl J Med"},{"key":"382_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM199102283240902","volume":"324","author":"SA Bozzette","year":"1991","unstructured":"Bozzette SA, Larsen RA, Chiu J, Leal MA, Jacobsen J, Rothman P, Robinson P, Gilbert G, McCutchan JA, Tilles J, Leedom JM, Richman D: A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med. 1991, 324: 580-4.","journal-title":"N Engl J Med"},{"key":"382_CR11","unstructured":"Anon: Diflucan\u00ae partnership programme. (accessed September 29, 2005), [http:\/\/www.diflucanpartnership.com]"},{"key":"382_CR12","first-page":"651","volume-title":"Br J Hosp Med","author":"A Gordon","year":"1972","unstructured":"Gordon A, Parsons M: The place of corticosteroids in the management of tuberculous meningitis. Br J Hosp Med. 1972, 651-5."},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2165\/00003088-200443110-00003","volume":"43","author":"D Panomvana Na Ayudhya","year":"2004","unstructured":"Panomvana Na Ayudhya D, Thanompuangseree N, Tansuphaswadikul S: Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Clin Pharmacokinet. 2004, 43: 725-32. 10.2165\/00003088-200443110-00003.","journal-title":"Clin Pharmacokinet"},{"key":"382_CR14","volume-title":"American Public Health Association 129th Annual Meeting, Atlanta, Georgia, Oct 21\u201325","author":"B Haile","year":"2001","unstructured":"Haile B, Maartens G, Wood R: Economic evaluation of cryptococcal meningitis and inpatient tuberculosis treatment for HIV-infected adults in South Africa (abstract number 25431). American Public Health Association 129th Annual Meeting, Atlanta, Georgia, Oct 21\u201325. 2001"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/00002030-200106150-00009","volume":"15","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Maartens G: Initiating co-trimoxazole prophylaxis in adult HIV-infected patients in Africa: an evaluation of the provisional WHO\/UNAIDS recommendations. AIDS. 2001, 15: 1143-8. 10.1097\/00002030-200106150-00009.","journal-title":"AIDS"},{"key":"382_CR16","first-page":"583","volume":"91","author":"FA Post","year":"2001","unstructured":"Post FA, Badri M, Wood R, Maartens G: AIDS in Africa \u2013 survival according to AIDS-defining illness. S Afr Med J. 2001, 91: 583-6.","journal-title":"S Afr Med J"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/jac\/dkh361","volume":"54","author":"B Sar","year":"2004","unstructured":"Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y: Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother. 2004, 54: 563-5. 10.1093\/jac\/dkh361.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-6-118\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:42:03Z","timestamp":1630449723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-6-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,18]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-6-118","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,18]]},"assertion":[{"value":"17 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}